Metabolic profiling of epithelial ovarian cancer cell lines: Evaluation of harvesting protocols for profiling using NMR spectroscopy

Bioanalysis

Volumn 7, Issue 2, 2015, Pages 157-166

  Engskog, Mikael K R ^a   Björklund, My ^b   Haglöf, Jakob ^a   Arvidsson, Torbjörn ^a,c   Shoshan, Maria ^b   Pettersson, Curt ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Medical Product Agency ^*  (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

METHANOL;

ARTICLE; CANCER RESISTANCE; CELL METABOLISM; CLINICAL PROTOCOL; CONTROLLED STUDY; FREEZE THAWING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OVARIAN CANCER CELL LINE; OVARY CARCINOMA; PHENOTYPE; REPRODUCIBILITY; SURVIVAL RATE; COMPARATIVE STUDY; DRUG RESISTANCE; FACTUAL DATABASE; FEMALE; FREEZING; HUMAN; METABOLISM; METABOLOME; METABOLOMICS; NEOPLASM; OVARY TUMOR; PATHOLOGY; PRINCIPAL COMPONENT ANALYSIS; TUMOR CELL LINE;

CELL LINE, TUMOR; DATABASES, FACTUAL; DRUG RESISTANCE, NEOPLASM; FEMALE; FREEZING; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; METABOLOME; METABOLOMICS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PRINCIPAL COMPONENT ANALYSIS; REPRODUCIBILITY OF RESULTS;

EID: 84921386334     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.14.235     Document Type: Article

References (37)

1. Landen CN Jr, Birrer MJ, Sood AK. Early events in the pathogenesis of epithelial ovarian cancer. J. Clin. Oncol. 26(6), 995-1005 (2008
2. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 144(5), 646-674 (2011
3. Ward PS, Thompson CB. Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate. Cancer Cell 21(3), 297-308 (2012
4. Vermeersch KA, Styczynski MP. Applications of metabolomics in cancer research. J. Carcinog. 12, 9 (2013
5. Deberardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 7(1), 11-20 (2008
6. Griffin JL, Shockcor JP. Metabolic profiles of cancer cells. Nat. Rev. Cancer 4(7), 551-561 (2004
7. Critelli G. Junctional reciprocating fast-slow reentry tachycardias. Diagnostic characterization and therapeutic possibilities. Cardiologia 36(Suppl. 8), 63-70 (1991
8. Jose C, Bellance N, Rossignol R. Choosing between glycolysis and oxidative phosphorylation: a tumor's dilemma?. Biochim. Biophys. Acta 1807(6), 552-561 (2011
9. Oliver SG, Winson MK, Kell DB, Baganz F. Systematic functional analysis of the yeast genome. Trends Biotechnol. 16(9), 373-378 (1998
10. Zhou M, Guan W, Walker LD. et al. Rapid mass spectrometric metabolic profiling of blood sera detects ovarian cancer with high accuracy. Cancer Epidemiol. Biomarkers Prev. 19(9), 2262-2271 (2010
11. Odunsi K, Wollman RM, Ambrosone CB. et al. Detection of epithelial ovarian cancer using 1H-NMR-based metabonomics. Int. J. Cancer 113(5), 782-788 (2005
12. Zhang T, Wu X, Ke C. et al. Identification of potential biomarkers for ovarian cancer by urinary metabolomic profiling. J. Proteome Res. 12(1), 505-512 (2013
13. Chen J, Zhang X, Cao R. et al. Serum 27-nor-5betacholestane- 3,7,12,24,25 pentol glucuronide discovered by metabolomics as potential diagnostic biomarker for epithelium ovarian cancer. J. Proteome Res. 10(5), 2625-2632 (2011
14. Guan W, Zhou M, Hampton CY. et al. Ovarian cancer detection from metabolomic liquid chromatography/mass spectrometry data by support vector machines. BMC Bioinformatics 10, 259 (2009
15. Fong MY, McDunn J, Kakar SS. Identification of metabolites in the normal ovary and their transformation in primary and metastatic ovarian cancer. PLoS ONE 6(5), e19963 (2011
16. Denkert C, Budczies J, Kind T. et al. Mass spectrometrybased metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors. Cancer Res. 66(22), 10795-10804 (2006
17. Lindon JC, Holmes E, Bollard ME, Stanley EG, Nicholson JK. Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis. Biomarkers 9(1), 1-31 (2004
18. Zhang S, Nagana Gowda GA, Ye T, Raftery D. Advances in NMR-based biofluid analysis and metabolite profiling. Analyst 135(7), 1490-1498 (2010
19. Leon Z, Garcia-Canaveras JC, Donato MT, Lahoz A. Mammalian cell metabolomics: experimental design and sample preparation. Electrophoresis 34(19), 2762-2775 (2013
20. Bi H, Krausz KW, Manna SK, Li F, Johnson CH, Gonzalez FJ. Optimization of harvesting, extraction, and analytical protocols for UPLC-ESI-MS-based metabolomic analysis of adherent mammalian cancer cells. Anal. Bioanal. Chem. 405(15), 5279-5289 (2013
21. Jonge L, Douma R, Heijnen J, Gulik W. Optimization of cold methanol quenching for quantitative metabolomics of Penicillium chrysogenum. Metabolomics 8(4), 727-735 (2012
22. Sellick CA, Hansen R, Maqsood AR. et al. Effective quenching processes for physiologically valid metabolite profiling of suspension cultured mammalian cells. Anal. Chem. 81(1), 174-183 (2009
23. Wintzell M, Lofstedt L, Johansson J, Pedersen AB, Fuxe J, Shoshan M. Repeated cisplatin treatment can lead to a multiresistant tumor cell population with stem cell features and sensitivity to 3-bromopyruvate. Cancer Biol. Ther. 13(14), 1454-1462 (2012
24. Viant MR. Revealing the metabolome of animal tissues using 1H nuclear magnetic resonance spectroscopy. Methods Mol. Biol. 358, 229-246 (2007
25. Teng Q, Huang W, Collette T, Ekman D, Tan C. A direct cell quenching method for cell-culture based metabolomics. Metabolomics 5(2), 199-208 (2009
26. Beckonert O, Keun HC, Ebbels TM. et al. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat. Protoc. 2(11), 2692-2703 (2007
27. Sumner LW, Amberg A, Barrett D. et al. Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI). Metabolomics 3(3), 211-221 (2007
28. Wishart DS, Tzur D, Knox C. et al. HMDB: the Human Metabolome Database. Nucleic Acids Res. 35, D521-D526 (2007
29. Wishart DS, Jewison T, Guo AC. et al. HMDB 3.0 - The Human Metabolome Database in 2013. Nucleic Acids Res. 41, D801-D807 (2013
30. Want EJ, Wilson ID, Gika H. et al. Global metabolic profiling procedures for urine using UPLC-MS. Nat. Protoc. 5(6), 1005-1018 (2010
31. Eriksson L, Johansson E, Kettaneh-Wold N, Trygg J, Wikström C, Wold S. Multi- and Megavariate Data Analysis, Part I: Basics Principles and Applications. Umeå University, Umetrics Inc., Umeå, Sweden (2006
32. Trygg J, Wold S. Orthogonal projections to latent structures (O-PLS). J. Chemom. 16(3), 119-128 (2002
33. Alison MR, Lin WR, Lim SM, Nicholson LJ. Cancer stem cells: in the line of fire. Cancer Treat. Rev. 38(6), 589-598 (2012
34. Bapat SA, Mali AM, Koppikar CB, Kurrey NK. Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Res. 65(8), 3025-3029 (2005
35. Zhang WC, Shyh-Chang N, Yang H. et al. Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis. Cell 148(1-2), 259-272 (2012
36. Cao MD, Sitter B, Bathen TF. et al. Predicting long-term survival and treatment response in breast cancer patients receiving neoadjuvant chemotherapy by MR metabolic profiling. NMR Biomed. 25(2), 369-378 (2012
37. Silva LP, Lorenzi PL, Purwaha P, Yong V, Hawke DH, Weinstein JN. Measurement of DNA concentration as a normalization strategy for metabolomic data from adherent cell lines. Anal. Chem. 85(20), 9536-9542 (2013